Cognitive resilience following paediatric stroke: Biological and environmental predictors.


Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 11 08 2019
revised: 18 11 2019
accepted: 24 11 2019
pubmed: 24 12 2019
medline: 18 8 2020
entrez: 24 12 2019
Statut: ppublish

Résumé

Little is known about resilience after paediatric stroke (PS), or the factors that contribute to better outcomes. Rather, research emphasis has been on impairment, measured through cross-sectional or retrospective designs, often heavily weighted to children presenting for clinical or rehabilitation follow-up. Implementing a resilience framework, this study aimed to investigate cognitive recovery post-stroke and factors that contribute to cognitive resilience at 12 months following PS. In a single site, prospective, longitudinal study (baseline, 1, 6, 12 months post-stroke), 61 children (55.7% male) aged 0-18 years, with a diagnosis of acute arterial ischemic stroke were recruited. Neurological status, lesion and child characteristics were collected at diagnosis. Cognitive, language and motor skills were assessed directly using age-appropriate, standardised tools. Parents rated their mental health, and child social and adaptive abilities. Participants were classified as 'resilient' (74%) or 'vulnerable' based on 12-month cognitive scores. The resilient group demonstrated more intact acute neurological status and higher language and adaptive abilities 1-month post-stroke; 88% of the vulnerable group had strokes involving both cortical and subcortical regions. Neonatal stroke, large lesions, cortical-only lesions, and middle cerebral artery involvement were associated with poorer cognition over the 12 months post-stroke. Absence of seizures and older age at stroke predicted better cognitive outcomes. In summary, most children surviving PS are cognitively resilient at 12 months post-insult. Risk and protective factors identified may guide targeted clinical intervention for more vulnerable children. Future research is needed to explore cognitive resilience trajectories beyond 12 months post-stroke.

Identifiants

pubmed: 31866101
pii: S1090-3798(19)30420-9
doi: 10.1016/j.ejpn.2019.11.011
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-58

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest There are no conflicts of interest to declare.

Auteurs

Vicki Anderson (V)

Clinical Sciences, Murdoch Children's Research Institute (MCRI), Australia; Psychology Service, The Royal Children's Hospital (RCH), Australia; Department of Paediatrics, University of Melbourne (UoM), Australia; School of Psychological Sciences, UoM, Australia. Electronic address: vicki.anderson@rch.org.au.

Simone Darling (S)

Clinical Sciences, Murdoch Children's Research Institute (MCRI), Australia.

Mark Mackay (M)

Clinical Sciences, Murdoch Children's Research Institute (MCRI), Australia; Neurology, RCH, Australia.

Paul Monagle (P)

Clinical Sciences, Murdoch Children's Research Institute (MCRI), Australia; Department of Paediatrics, University of Melbourne (UoM), Australia; Haemtology, RCH, Australia.

Mardee Greenham (M)

Clinical Sciences, Murdoch Children's Research Institute (MCRI), Australia; School of Psychological Sciences, UoM, Australia.

Anna Cooper (A)

Clinical Sciences, Murdoch Children's Research Institute (MCRI), Australia; School of Psychological Sciences, UoM, Australia.

Rod W Hunt (RW)

Clinical Sciences, Murdoch Children's Research Institute (MCRI), Australia; Department of Paediatrics, University of Melbourne (UoM), Australia; Neonatal Medicine, RCH, Australia.

Stephen Hearps (S)

Clinical Sciences, Murdoch Children's Research Institute (MCRI), Australia.

Anne L Gordon (AL)

Evelina London Children's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK; Division of Health and Social Care Research, King's College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH